Atul is an API manufacturer based in India. It holds one active US drug master file. Its GMP standing is certified by CDSCO (India). Customs aggregates show $126.0M of exports covering 2,871 molecules to 81 destinations in 2025.
| Site | FDA FEI |
|---|---|
| at post atulatul 396 020valsad, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Dapsone | SFDA (Saudi Arabia), US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $25.0M | 50 |
| 2025 | Not reported | $126.0M | 81 |
| 2024 | Not reported | $141.7M | 67 |
| 2023 | Not reported | $110.6M | 64 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Atul comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.